Vietnam has an emerging aquaculture vaccine market, driven by the growth in the country's sea-food industry and the increasing use of disease prevention measures. The market is estimated to grow at a CAGR of 7.8% during the period between 2025 and 2035 and reach more than USD 72.6 million by 2025.
| Attributes | Insights |
|---|---|
| Estimated Market Size (2025) | USD 72.6 million |
| Value-based CAGR (2025 to 2035) | 7.8% |
Vietnam is one of the world's leading exporters in seafood and aquaculture significantly contributes to its GDP. However, diseases have always been a challenge, significantly affecting fish and shrimp production and substantial economic losses. Therefore, vaccines have to be a part of counteracting such risks, improving yields, and enhancing quality in exports.
Government policies regarding sustainable aquaculture and maintaining international trade standards are forcing vaccine use over antibiotics. Investment of local and international vaccine manufacturers in R&D, rising awareness among aquaculture farmers, are all driving the market forward.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Transition to Preventive Health in Fish Farming
More Vietnamese fish farms use vaccines instead of antibiotics. The application of such vaccine practices meets global standards in food safety while inhibiting antibiotic-resistant bacteria spread.
Emphasis on Shrimp and Catfish Farming
Aquaculture in Vietnam is primarily shrimp and pangasius catfish. The vaccines required for the disease such as WSSV and Aeromonas in these fish are very significant.
Collaboration Between Public and Private Sectors
Partnerships involving government agencies, research centers, and private companies are essential for creating new vaccines and ensuring they are available to local fish farms.
Demand for New Vaccine Delivery Methods
Developments in vaccine delivery, such as oral and immersion methods, aim to make the process more efficient and reduce stress on the fish.
| Industry | Growth Trends |
|---|---|
| Shrimp Farming | Vaccines targeting white spot syndrome virus (WSSV) and Vibrio infections dominate this segment. |
| Pangasius Farming | Farmers increasingly use vaccines to combat bacterial pathogens such as Edwardsiella and Aeromonas. |
| Tilapia Farming | Demand for vaccines against Streptococcus in tilapia farming is growing due to rising export potential. |
Inactivated Vaccines
Inactivated vaccines dominate Vietnam’s market due to their proven safety and efficacy. These vaccines are widely used in fish species like pangasius and tilapia.
Live Attenuated Vaccines
Live attenuated vaccines are increasingly adopted for their long-lasting immunity, particularly in high-value species such as shrimp.
DNA Vaccines
Although in the nascent stage, DNA vaccines are gaining attention for their targeted action against viral infections like iridovirus and nodavirus.
Multivalent Vaccines
Farmers prefer multivalent vaccines for cost savings and convenience, as they provide protection against multiple pathogens in a single dose.
Vietnam’s aquaculture vaccines market is moderately consolidated, with global companies leading the premium segment and domestic firms focusing on affordable solutions.
Conclusion
Global players like MSD Animal Health and Elanco dominate the market with advanced vaccines for export-driven aquaculture species. Domestic manufacturers, including NAVETCO and Vemedim, play a crucial role in supplying cost-effective solutions tailored to local needs. Collaborations between international companies and Vietnamese research institutions further strengthen the market.
| Vendor Tier | Tier 1 |
|---|---|
| Key Vendors | MSD Animal Health, Elanco, Zoetis |
| Market Share (%) | 60% |
| Description | Leading global manufacturers providing innovative vaccines with proven efficacy. |
| Vendor Tier | Tier 2 |
|---|---|
| Key Vendors | NAVETCO, Vemedim |
| Market Share (%) | 30% |
| Description | Local firms focusing on affordable, region-specific vaccines targeting shrimp and pangasius farming. |
| Vendor Tier | Tier 3 |
|---|---|
| Key Vendors | Benchmark Animal Health, Hipra |
| Market Share (%) | 10% |
| Description | Niche players offering advanced solutions, including multivalent and DNA vaccines. |
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Rising Export Demand for High-Quality Seafood
Global demand for Vietnamese seafood, particularly shrimp and pangasius, drives the adoption of vaccines to meet international quality and safety standards.
Government Support for Sustainable Aquaculture
Vietnam’s government promotes vaccination as part of its sustainable aquaculture strategies, offering subsidies and training programs for farmers.
High Economic Losses Due to Diseases
Frequent disease outbreaks in aquaculture, such as white spot syndrome and bacterial infections, make vaccines essential for minimizing losses and improving productivity.
Limited Farmer Awareness Due to its Demand
Small-scale aquaculture farmers in rural areas often lack knowledge about vaccine benefits, leading to slower adoption rates.
High Initial Costs
The relatively high cost of vaccines compared to antibiotics remains a barrier, particularly for small and medium-sized enterprises (SMEs) in the aquaculture sector.
Cold Chain Requirements
The need for cold chain logistics poses challenges for vaccine distribution in remote farming regions, increasing operational costs.
| Date | Jul 2024 |
|---|---|
| Company | Elanco |
| Update | Partnered with Vietnamese research institutes to develop multivalent vaccines for shrimp and tilapia. |
| Date | Sep 2024 |
|---|---|
| Company | Vemedim |
| Update | Expanded its vaccine production capacity to meet growing domestic demand. |
| Date | Nov 2024 |
|---|---|
| Company | Hipra |
| Update | Debuted a DNA vaccine for iridovirus in high-value fish species farmed in Vietnam. |
It is expected that by 2035, the market for aquaculture vaccines in Vietnam will increase to USD 165.4 million because of improvements in vaccine technologies, increased export demand, and support from the government for sustainable practices. DNA and multivalent vaccines are likely to be accepted as a means of addressing the complex issues that diseases present to shrimp and fish farming.
The collaboration between international and domestic players will enhance innovation and ensure better accessibility to high-quality vaccines. Improved farmer education and cold chain logistics will increase adoption rates.
The future of the sector will be well sustained and profitable since Vietnam is emerging as a strong global seafood exporting country.
Major players include MSD Animal Health, Elanco, NAVETCO, and Vemedim
Rising export demand, government support, and economic losses from disease outbreaks are key drivers.
Limited farmer awareness, high initial costs, and cold chain logistics are significant challenges.
Shrimp and pangasius farming lead vaccine adoption due to their economic importance in Vietnam’s aquaculture sector.
The market is expected to grow at a growth rate of 7.8% from 2025 to 2035.
Explore Animal Health Therapeutics Insights
View Reports
Vietnam Aquaculture Vaccines Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
